• Perrine Leprêtre, Thomas Clavier, Anne-Lise Ménard, Steven Grange, Christophe Girault, and Déborah Boyer.
• Department of Medical Intensive Care, Rouen University Hospital, 76000 Rouen, France.
• J Crit Care. 2019 Dec 1; 54: 122-124.

PurposeWe describe what we believe to be the first two cases of patients who received an allograft in intensive care unit (ICU) despite severe septic shock with multi-organ failure (MOF).ResultsOne patient had aggressive large B-cell lymphoma. After allograft, the patient initially improved after withdrawing norepinephrine and renal replacement therapy but he subsequently died thirty-two days later because of a new relapse of the disease. The second patient had acute myeloid leukemia type 1 with a need for an allograft after a first complete remission. She was discharged from ICU at D23 after allograft and still alive 7 months later with complete remission. For the two patients, allograft conditioning was performed before admission to our ICU. These two cases highlight one major problem in such situations which is to find the best time to perform the allograft, particularly in ventilated patients with septic shock and MOF. We performed the allograft when we thought that the risk-benefit ratio was in favor of restoring immunity.ConclusionAllograft should be considered as a rescue therapy in ICU for patients with aplasia, during septic shock with multi-organ failure, however close multidisciplinary discussion is required between intensivists and onco-hematologists.Copyright © 2019. Published by Elsevier Inc.

27 keywords...

hide…